Literature DB >> 2784621

Frequency of autoantibodies in normal children.

A Martini1, R Lorini, D Zanaboni, A Ravelli, R G Burgio.   

Abstract

Very few data have been reported on the frequency of autoantibodies (AAs) in normal children. In the present study we investigated the frequency of 14 AAs in a total of 268 apparently normal children (151 boys and 117 girls; age range, 1 month to 14 years). Forty-one children (22 boys and 19 girls) were positive for at least one AA, usually in a low titer; two children were positive for two AAs. None of these children had a personal or family history of autoimmune diseases. The percentage of children positive for each AA was as follows: antinuclear, 3%; anti-smooth muscle, 2.6%; antireticulin, 2.6%; antimitochondrial, 1.1%; rheumatoid factor, 0.6%; antiribosomal, 0.4%; anti-gastric parietal cells, 5.2%; and anti-thyroid microsomal, 1.3%. Anti-double-stranded DNA, anti-intestinal epithelial cells, antiliver and antikidney microsomal, antithyroglobulin, anti-islet cells, and complement-fixing anti-islet cell antibodies were not detected in any serum. Fifteen of the 41 positive children were checked for the presence of AAs two years later; six (40%) were still positive, always for the same AA, without major differences in titer. Our results suggest that the overall frequency of AAs in apparently healthy children is quite similar to that reported in young adults; this AA positivity seems most often to represent a transient phenomenon.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784621     DOI: 10.1001/archpedi.1989.02150160123025

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  8 in total

1.  Natural antibodies in childhood: development, individual stability, and injury effect indicate a contribution to immune memory.

Authors:  P Mirilas; C Fesel; B Guilbert; N G Beratis; S Avrameas
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

2.  No interference of rheumatoid factor(s) with toxoplasmosis IgM determination in infancy.

Authors:  O Djurković-Djaković; N Milosević-Jovcić; S Zerjav; D Sibalić
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

Review 3.  Immunological features of diffuse connective tissue diseases.

Authors:  G R Burgio; A Martini
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

4.  Osteoarticular brucellosis in children.

Authors:  Y A al-Eissa; A M Kambal; A A Alrabeeah; A M Abdullah; N A al-Jurayyan; N M al-Jishi
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

5.  Prevalence and Significance of Autoantibodies in Children With Acute Liver Failure.

Authors:  Michael R Narkewicz; Simon Horslen; Steven H Belle; David A Rudnick; Vicky L Ng; Philip Rosenthal; Rene Romero; Kathleen M Loomes; Song Zhang; Regina M Hardison; Robert H Squires
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

6.  Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.

Authors:  Heather M Patton; Joel E Lavine; Mark L Van Natta; Jeffrey B Schwimmer; David Kleiner; Jean Molleston
Journal:  Gastroenterology       Date:  2008-09-03       Impact factor: 22.682

7.  Serum IgG Profiling of Toddlers Reveals a Subgroup with Elevated Seropositive Antibodies to Viruses Correlating with Increased Vaccine and Autoantigen Responses.

Authors:  Patricia Pichilingue-Reto; Prithvi Raj; Quan-Zhen Li; Igor Dozmorov; David R Karp; Edward K Wakeland; Morgan Nelson; Rebecca S Gruchalla; M Teresa de la Morena; Nicolai S C van Oers
Journal:  J Clin Immunol       Date:  2021-03-03       Impact factor: 8.317

8.  Collagenous Gastritis in Children: Incidence, Disease Course, and Associations With Autoimmunity and Inflammatory Markers.

Authors:  Timo Käppi; Alkwin Wanders; Mats Wolving; Christine Lingblom; Birgitta Davidsson Bården; Rikard Arkel; Josefine Hätting; Johan Anderzén; Christine Wennerås; Robert Saalman
Journal:  Clin Transl Gastroenterol       Date:  2020-08       Impact factor: 4.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.